Multiple Peptide Systems, a wholly owned subsidiary ofHoughten Pharmaceuticals of San Diego, has been certifiedunder the FDA's Good Manufacturing Practices guidelines as oneof only a few commercial facilities in the U.S. to manufacturepeptides for drug discovery research and development.
The company produced its first peptide under GMP standardsfor the Walter Reed Army Institute of Research, whichselected Multiple Peptide Systems to manufacture peptides fora vaccine that appeared to prevent malaria.
The company has completed animal testing of the vaccine andwill soon begin clinical trials in the U.S. Preliminary resultsfrom Walter Reed indicate that the company's peptides are atleast as effective as the vaccine.
Multiple Peptide Systems has used the "Tea Bag Method" ofproducing peptides since its founding in 1986. It upgraded tosatisfy meticulous GMP standards in 1991.
(c) 1997 American Health Consultants. All rights reserved.